FDA to ease copycat drug rules, speeding access to cheaper drugs

The U.S. Food and Drug Administration (FDA) announced Wednesday that it will relax certain rules for approving low-cost versions of some high-priced medications, in an effort to speed up access to ...
Health AffairsOpinion

Advancing The Development Of Non-Opioid Analgesics For Chronic Pain

There are three obstacles to faster development and deployment of non-addictive pain treatments. They are the business ...
STATOpinion

A $20 over-the-counter drug in Europe requires a prescription and $800 in the U.S.

A month’s supply of Miebo requires $800 and a prescription in the U.S. In Europe, it’s over-the-counter and $20.

4DMT Announces Exclusive License Agreement with Otsuka Pharmaceutical Co., Ltd. for Development and Commercialization of 4D-150 in Asia-Pacific

DMT to receive $85 million upfront cash payment and expect to receive at least $50 million of cost sharing from Otsuka over the next three years ...

BioNxt Reports “Readiness to Grant” Patent Notification from the Eurasian Patent Organization

BioNxt Solutions Inc. (“BioNxt” or the “Company”) (CSE:BNXT) (OTCQB:BNXTF) (FSE:BXT), a bioscience innovator specializing in ...
TMCnet

Laxxon Medical to Attend BIO-Europe and Jefferies Healthcare Conference World Premier Life Science Partnering Events

Laxxon Medical, a leading pharmaceutical technology company, pioneering a new generation of advanced oral drug delivery systems, today announced that it will be attending BIO-Europe 2025 and the ...